Project ID: 97556

Sinopharm donates laboratory equipment to Bolivia in June 2021

Summary

Funding agency [Type]

China National Pharmaceutical Group Corporation (Sinopharm) [State-owned Company]

Recipient

Bolivia

Sector

Health (Code: 120)

Flow type

Grant

Infrastructure

No

COVID

Yes

Category

Intent

Development (The next section lists the possible statuses.)

Commercial

Development

Representational

Mixed

Financial Flow Classification

ODA-like (The next section lists the possible statuses.)

Official Development Assistance

Other Official Flows

Vague (Official Finance)

Flows categorized based on OECD-DAC guidelines

Project lifecycle

Status

Completion (The next section lists the possible statuses.)

Pledge

Commitment

Implementation

Completion

Suspended

Cancelled

Milestones

Commitment

2021-06-21

Actual start

2021-06-21

Planned complete

2021-06-25

Actual complete

2021-06-21

Geography

Description

In June 2021, China National Pharmaceutical Group Corporation (Sinopharm) donated laboratory equipment to the Bolivian National Institute of Health Laboratories (INLASA). The donation arrived at Jorge Wilstermann International Airport in Cochabamba on June 21, along with a purchased batch of Sinopharm COVID-19 vaccines. The donation was for the purpose of assisting Bolivia in its fight against COVID-19. The laboratory equipment was to be used for conducting PCR and blood analysis, although what exact equipment was donated is unclear.

Number of official sources

2

Number of total sources

5

Download the dataset

Details

Cofinanced

No

Direct receiving agencies [Type]

Bolivia National Health Laboratories Institute (INLASA) [Government Agency]